D.E. Shaw & Co
PJP icon

D.E. Shaw & Co’s Invesco Pharmaceuticals ETF PJP Stock Holding History

D.E. Shaw & Co’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,793
Closed -$224K – 4772
2024
Q1 		$224K Buy
+2,793
New +$216K ﹤0.01% 3882

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co's PJP Position: Q2 2024 in Review

D.E. Shaw & Co sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2024, closing a stake of 2,793 shares — an estimated $224K sold.

D.E. Shaw & Co first reported a position in PJP in Q1 2024 and held it in 1 quarter. The position peaked at $224K in Q1 2024. 89 funds tracked by Wall St. Rank hold PJP as of Q2 2024.

  • D.E. Shaw & Co reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,793 Invesco Pharmaceuticals ETF shares in Q2 2024, an estimated $224K.
  • D.E. Shaw & Co first reported a position in Invesco Pharmaceuticals ETF in Q1 2024 and held it in 1 quarter.
  • D.E. Shaw & Co's Invesco Pharmaceuticals ETF position peaked at $224K in Q1 2024.
  • 89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.